Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PTH vs DWAS
Shared holdings
49
PTH covered by DWAS
41.27%
DWAS covered by PTH
41.27%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PTH (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.67% | |
| Invesco Private Government Fund | 7.65% | |
| PRAXIS PRECISION MEDICINES INC | 4.01% | |
| GUARDANT HEALTH INC | 3.37% | |
| ROIVANT SCIENCES | 3.21% | |
| TERNS PHARMACEUTICALS INC | 3.16% | |
| ARROWHEAD PHARMACEUTICALS INC | 3.16% | |
| NATERA INC | 2.68% | |
| REVOLUTION MEDICINES INC | 2.50% | |
| TENET HEALTHCARE CORP | 2.24% | |
| AXSOME THERAPEUTICS INC | 2.19% | |
| HCA HEALTHCARE INC | 2.15% | |
| CELCUITY INC | 2.14% | |
| MEDPACE HOLDINGS INC | 2.12% | |
| UNITED THERAPEUTICS CORP DEL | 1.93% | |
| BRIDGEBIO PHARMA INC | 1.90% | |
| MADRIGAL PHARMACEUTICALS INC | 1.77% | |
| COGENT BIOSCIENCES INC | 1.72% | |
| TRAVERE THERAPEUTICS INC | 1.55% | |
| PROTAGONIST THERAPEUTICS INC | 1.44% | |
| ENSIGN GROUP INC | 1.42% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.42% | |
| STOKE THERAPEUTICS INC | 1.39% | |
| ALIGNMENT HEALTHCARE INC | 1.33% | |
| HARROW INC | 1.25% | |
| PACS GROUP INC | 1.21% | |
| IMMUNOME INC | 1.16% | |
| MIRUM PHARMACEUTICALS INC | 1.13% | |
| TAYSHA GENE THERAPIES INC | 1.03% | |
| ARCUTIS BIOTHERAPEUTICS INC | 1.01% | |
| PTC THERAPEUTICS INC | 1.00% | |
| RAPT THERAPEUTICS INC | 1.00% | |
| LIGAND PHARMACEUTICALS | 0.90% | |
| NUVATION BIO INC | 0.88% | |
| IDEAYA BIOSCIENCES | 0.87% | |
| ALPHATEC HOLDINGS INC | 0.86% | |
| TARSUS PHARMACEUTICALS INC | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.84% | |
| AMNEAL PHARM INC | 0.81% | |
| AXOGEN INC | 0.79% | |
| PRECIGEN INC | 0.71% | |
| KODIAK SCIENCES INC | 0.70% | |
| MONTE ROSA THERAPEUTICS INC | 0.66% | |
| PALVELLA THERAPEUTICS INC | 0.63% | |
| SIONNA THERAPEUTICS INC | 0.63% | |
| MAZE THERAPEUTICS INC | 0.63% | |
| REPLIMUNE GROUP INC | 0.62% | |
| TREVI THERAPEUTICS INC | 0.62% | |
| UPSTREAM BIO INC | 0.60% | |
| ORUKA THERAPEUTICS INC | 0.60% |
DWAS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 18.21% | |
| Invesco Private Government Fund | 6.94% | |
| BEL FUSE INC NV CL B | 1.41% | |
| TERNS PHARMACEUTICALS INC | 1.18% | |
| SEZZLE INC | 1.15% | |
| PLANET LABS PBC A | 1.12% | |
| TUTOR PERINI CORP | 1.11% | |
| LUMENTUM HOLDINGS INC | 1.05% | |
| KODIAK SCIENCES INC | 1.03% | |
| CELCUITY INC | 1.02% | |
| GRAHAM CORPORATION | 0.99% | |
| NUVALENT INC-A | 0.94% | |
| PRAXIS PRECISION MEDICINES INC | 0.87% | |
| COGENT BIOSCIENCES INC | 0.82% | |
| FREQUENCY ELECTRONICS INC | 0.81% | |
| AMNEAL PHARM INC | 0.80% | |
| IDAHO STRATEGIC RESOURCES | 0.76% | |
| ALUMIS INC | 0.74% | |
| ENOVA INTL INC | 0.73% | |
| TTM TECHNOLOGIES INC | 0.68% | |
| VSE CORP | 0.67% | |
| RAPT THERAPEUTICS INC | 0.66% | |
| NORTHEAST BANK | 0.63% | |
| ECHOSTAR CORP CL A | 0.59% | |
| INHIBRX BIOSCIENCES INC | 0.59% | |
| MYR GROUP INC/DELAWARE | 0.58% | |
| PRIMORIS SVCS CORP | 0.57% | |
| PERIMETER SOLUTIONS SA | 0.53% | |
| UFP TECHNOLOGIES INC | 0.53% | |
| GRANITE CONSTRUCTION INC | 0.52% | |
| VICOR CORPORATION | 0.52% | |
| NLIGHT INC | 0.52% | |
| RESOLUTE HOLDINGS MANAGEMENT INC | 0.51% | |
| BRIGHTSPHERE INVESTMENT GROUP INC | 0.50% | |
| CENTURY ALUMINUM COMPANY | 0.47% | |
| BIOAGE LABS INC | 0.46% | |
| US LIME & MINERA | 0.45% | |
| PALVELLA THERAPEUTICS INC | 0.45% | |
| LINCOLN EDUCATIONAL SERVICES | 0.45% | |
| RHYTHM PHARMACEUTICALS INC | 0.45% | |
| PHATHOM PHARMACEUTICALS INC | 0.45% | |
| VIAVI SOLUTIONS INC | 0.44% | |
| FORUM ENERGY TECHNOLOGIES INC | 0.44% | |
| ADV ENERGY INDS | 0.42% | |
| ASTRONICS CORP | 0.41% | |
| GUARDANT HEALTH INC | 0.41% | |
| AXSOME THERAPEUTICS INC | 0.40% | |
| SEPTERNA INC | 0.40% | |
| EZCORP INC CL A NON VTG | 0.40% | |
| BROOKDALE SR | 0.40% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.